Evolution of the Average Target: Exelon Corporation

Evolution of the Target Price: Exelon Corporation

Changes in Analyst Recommendations: Exelon Corporation

a1.gT8-ezSjlbzHkMgAcds5MEAkPHkjajeOkDYdH2fbUG4.tVpaAXrmofqjqaBOQ5luaggJSi9GIQfgpGNEUgmBCTzmbn02Z5X-5P_J_A~385b3962d3e41d2c0c078f47194a05ab
Morgan Stanley Adjusts Exelon Price Target to $48 From $49, Maintains Equal Weight Rating May. 22 MT
KeyBanc Downgrades Exelon to Underweight From Sector Weight, Price Target is $39 May. 14 MT
Analyst recommendations: AbbVie, KKR, Merck, Toast, Uber… May. 14Our Logo
KeyBanc Downgrades Exelon to Underweight From Sector Weight, Price Target is $39 May. 14 MT
Guggenheim Adjusts Price Target on Exelon to $50 From $47 May. 02 MT
Wolfe Adjusts Price Target on Exelon to $50 From $47 May. 02 MT
Wells Fargo Adjusts Price Target on Exelon to $50 From $46 May. 02 MT
BMO Capital Adjusts Price Target on Exelon to $50 From $46, Maintains Outperform Rating Apr. 28 MT
Mizuho Adjusts Price Target on Exelon to $50 From $43, Maintains Outperform Rating Apr. 28 MT
Morgan Stanley Adjusts Price Target on Exelon to $49 From $48, Maintains Equalweight Rating Apr. 23 MT
Guggenheim Adjusts Price Target on Exelon to $47 From $46, Maintains Buy Rating Apr. 22 MT
Jefferies Adjusts Price Target on Exelon to $52 From $47, Maintains Buy Rating Apr. 22 MT
JPMorgan Adjusts Exelon Price Target to $48 From $47, Maintains Neutral Rating Apr. 17 MT
Evercore ISI Downgrades Exelon to In Line From Outperform Apr. 15 MT
Argus Research Adjusts Exelon Price Target to $48 From $45 Mar. 26 MT
UBS Adjusts Price Target on Exelon to $47 From $45, Keeps Neutral Rating Mar. 21 MT
Morgan Stanley Raises Exelon Price Target to $48 From $46, Maintains Equal Weight Rating Mar. 20 MT
Barclays Adjusts Price Target on Exelon to $48 From $42 Feb. 24 MT
Morgan Stanley Adjusts Price Target on Exelon to $46 From $45, Keeps Equalweight Rating Feb. 20 MT
Goldman Sachs Adjusts Exelon Price Target to $41 From $39 Feb. 14 MT
Scotiabank Adjusts Price Target on Exelon to $44 From $42, Maintains Sector Perform Rating Feb. 13 MT
Evercore ISI Adjusts Price Target on Exelon to $46 From $44, Maintains Outperform Rating Feb. 13 MT
Guggenheim Adjusts Price Target on Exelon to $46 From $44, Maintains Buy Rating Feb. 13 MT
Wells Fargo Raises Exelon's Price Target to $46 From $43 Feb. 12 MT
BMO Capital Adjusts Exelon Price Target to $46 From $44, Maintains Outperform Rating Feb. 04 MT
More recommendations

Consensus 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+7.43%
+20.1%
-11.19%
-6.69%
+2.47%
-1.59%
+2.12%
+9.46%
+5.86%
+5.57%
Average +3.35%
Weighted average by Cap. +2.99%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
43.67USD
Average target price
46.91USD
Spread / Average Target
+7.43%
High Price Target
52.00USD
Spread / Highest target
+19.07%
Low Price Target
39.00USD
Spread / Lowest Target
-10.69%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
KeyBanc Capital Markets
Guggenheim
Wolfe Research
Wells Fargo Securities
BMO Capital
Mizuho Securities
Jefferies & Co.
JPMorgan Chase
Evercore ISI
Argus
UBS
Barclays
Goldman Sachs
Scotiabank
RBC Capital Markets
BofA Securities
Seaport Global Securities
Credit Suisse
Vertical Research
Spin-Off Research
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EXC Stock
  4. Consensus Exelon Corporation
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
BENEFIT NOW